| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INSMED Inc | Director | Common Stock | 122K | $1.53M | $12.58 | May 13, 2024 | Direct |
| ALEXION PHARMACEUTICALS, INC. | Director | Common Stock, par value $.0001 per share | 0 | $177.00 | Jul 21, 2021 | Direct | |
| ALEXION PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | $155.01 | Jul 21, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INSM | INSMED Inc | May 13, 2024 | 1 | $0 | 4 | May 15, 2024 | Director |
| INSM | INSMED Inc | May 11, 2023 | 1 | $0 | 4 | May 15, 2023 | Director |
| INSM | INSMED Inc | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| INSM | INSMED Inc | Nov 1, 2021 | 1 | $302K | 4 | Nov 3, 2021 | Director |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Jul 21, 2021 | 4 | -$1.14M | 4 | Jul 23, 2021 | Director |
| ALXN | ALEXION PHARMACEUTICALS, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |
| INSM | INSMED Inc | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |